445 related articles for article (PubMed ID: 30025835)
1. Human polyspecific immunoglobulin attenuates group A streptococcal virulence factor activity and reduces disease severity in a murine necrotizing fasciitis model.
Tarnutzer A; Andreoni F; Keller N; Zürcher C; Norrby-Teglund A; Schüpbach RA; Zinkernagel AS
Clin Microbiol Infect; 2019 Apr; 25(4):512.e7-512.e13. PubMed ID: 30025835
[TBL] [Abstract][Full Text] [Related]
2. Intravenous immunoglobulin as adjunctive treatment for streptococcal toxic shock syndrome associated with necrotizing fasciitis: case report and review.
Cawley MJ; Briggs M; Haith LR; Reilly KJ; Guilday RE; Braxton GR; Patton ML
Pharmacotherapy; 1999 Sep; 19(9):1094-8. PubMed ID: 10610017
[TBL] [Abstract][Full Text] [Related]
3. Streptococcus pyogenes Transcriptome Changes in the Inflammatory Environment of Necrotizing Fasciitis.
Hirose Y; Yamaguchi M; Okuzaki D; Motooka D; Hamamoto H; Hanada T; Sumitomo T; Nakata M; Kawabata S
Appl Environ Microbiol; 2019 Nov; 85(21):. PubMed ID: 31471300
[No Abstract] [Full Text] [Related]
4. Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study.
Linnér A; Darenberg J; Sjölin J; Henriques-Normark B; Norrby-Teglund A
Clin Infect Dis; 2014 Sep; 59(6):851-7. PubMed ID: 24928291
[TBL] [Abstract][Full Text] [Related]
5. Clindamycin Affects Group A Streptococcus Virulence Factors and Improves Clinical Outcome.
Andreoni F; Zürcher C; Tarnutzer A; Schilcher K; Neff A; Keller N; Marques Maggio E; Poyart C; Schuepbach RA; Zinkernagel AS
J Infect Dis; 2017 Jan; 215(2):269-277. PubMed ID: 27247345
[TBL] [Abstract][Full Text] [Related]
6. Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production.
Norrby-Teglund A; Kaul R; Low DE; McGeer A; Newton DW; Andersson J; Andersson U; Kotb M
J Immunol; 1996 Apr; 156(8):3057-64. PubMed ID: 8609429
[TBL] [Abstract][Full Text] [Related]
7. Group A streptococcal necrotizing fasciitis of the eyelids and face managed with debridement and adjunctive intravenous immunoglobulin.
Aakalu VK; Sajja K; Cook JL; Ahmad AZ
Ophthalmic Plast Reconstr Surg; 2009; 25(4):332-4. PubMed ID: 19617804
[TBL] [Abstract][Full Text] [Related]
8. Successful management of severe group A streptococcal soft tissue infections using an aggressive medical regimen including intravenous polyspecific immunoglobulin together with a conservative surgical approach.
Norrby-Teglund A; Muller MP; Mcgeer A; Gan BS; Guru V; Bohnen J; Thulin P; Low DE
Scand J Infect Dis; 2005; 37(3):166-72. PubMed ID: 15849047
[TBL] [Abstract][Full Text] [Related]
9. Necrotizing fasciitis.
Cherneski CL; Embil JM
Saudi Med J; 2001 Jul; 22(7):565-8. PubMed ID: 11479634
[TBL] [Abstract][Full Text] [Related]
10. Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammation.
Sriskandan S; Ferguson M; Elliot V; Faulkner L; Cohen J
J Antimicrob Chemother; 2006 Jul; 58(1):117-24. PubMed ID: 16670109
[TBL] [Abstract][Full Text] [Related]
11. Hyperbaric oxygen therapy as further adjunctive therapy in the treatment of periorbital necrotizing fasciitis caused by group A Streptococcus.
Lazzeri D; Lazzeri S; Figus M; Agostini T; Nardi M; Pantaloni M
Ophthalmic Plast Reconstr Surg; 2010; 26(6):504-5; author reply 505. PubMed ID: 20811307
[No Abstract] [Full Text] [Related]
12. Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome.
Darenberg J; Söderquist B; Normark BH; Norrby-Teglund A
Clin Infect Dis; 2004 Mar; 38(6):836-42. PubMed ID: 14999628
[TBL] [Abstract][Full Text] [Related]
13. A survey of physician's attitudes regarding management of severe group A streptococcal infections.
Valiquette L; Low DE; Chow R; McGeer AJ
Scand J Infect Dis; 2006; 38(11-12):977-82. PubMed ID: 17148064
[TBL] [Abstract][Full Text] [Related]
14. Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment.
Stevens DL
Emerg Infect Dis; 1995; 1(3):69-78. PubMed ID: 8903167
[TBL] [Abstract][Full Text] [Related]
15. Trading Capsule for Increased Cytotoxin Production: Contribution to Virulence of a Newly Emerged Clade of emm89 Streptococcus pyogenes.
Zhu L; Olsen RJ; Nasser W; de la Riva Morales I; Musser JM
mBio; 2015 Oct; 6(5):e01378-15. PubMed ID: 26443457
[TBL] [Abstract][Full Text] [Related]
16. Group B streptococcal necrotizing fasciitis and toxic shock-like syndrome: a case report and review of the literature.
Crum NF; Wallace MR
Scand J Infect Dis; 2003; 35(11-12):878-81. PubMed ID: 14723367
[TBL] [Abstract][Full Text] [Related]
17. Group A Streptococcal DNase Sda1 Impairs Plasmacytoid Dendritic Cells' Type 1 Interferon Response.
Keller N; Woytschak J; Heeb LEM; Marques Maggio E; Mairpady Shambat S; Snäll J; Hyldegaard O; Boyman O; Norrby-Teglund A; Zinkernagel AS
J Invest Dermatol; 2019 Jun; 139(6):1284-1293. PubMed ID: 30543898
[TBL] [Abstract][Full Text] [Related]
18. Necrotizing soft tissue infections caused by Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis of groups C and G in western Norway.
Bruun T; Kittang BR; de Hoog BJ; Aardal S; Flaatten HK; Langeland N; Mylvaganam H; Vindenes HA; Skrede S
Clin Microbiol Infect; 2013 Dec; 19(12):E545-50. PubMed ID: 23795951
[TBL] [Abstract][Full Text] [Related]
19. [Necrotizing fasciitis of the eyelids and toxic shock syndrome due to Streptococcus pyogenes].
Bustos B R; Soto G G; Hickmann O L; Torres B C
Rev Chilena Infectol; 2009 Apr; 26(2):152-5. PubMed ID: 19621147
[TBL] [Abstract][Full Text] [Related]
20. Opsonic antibodies to the surface M protein of group A streptococci in pooled normal immunoglobulins (IVIG): potential impact on the clinical efficacy of IVIG therapy for severe invasive group A streptococcal infections.
Basma H; Norrby-Teglund A; McGeer A; Low DE; El-Ahmedy O; Dale JB; Schwartz B; Kotb M
Infect Immun; 1998 May; 66(5):2279-83. PubMed ID: 9573118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
